<bill session="108" type="h" number="780" updated="2013-07-14T19:00:47-04:00">
  <state datetime="2003-02-13">REFERRED</state>
  <status>
    <introduced datetime="2003-02-13"/>
  </status>
  <introduced datetime="2003-02-13"/>
  <titles>
    <title as="introduced" type="short">Prescription Drug Price Reduction Act</title>
    <title as="introduced" type="official">To amend the Federal Food, Drug, and Cosmetic Act to provide for the implementation of the program under section 804 of such Act, and for other purposes.</title>
  </titles>
  <sponsor id="400026"/>
  <cosponsors>
    <cosponsor id="400006" joined="2003-02-13"/>
    <cosponsor id="400007" joined="2003-03-06"/>
    <cosponsor id="400047" joined="2003-03-20"/>
    <cosponsor id="400084" joined="2003-02-13"/>
    <cosponsor id="400087" joined="2003-02-13"/>
    <cosponsor id="400121" joined="2003-02-13"/>
    <cosponsor id="400143" joined="2003-02-13"/>
    <cosponsor id="400166" joined="2003-02-13"/>
    <cosponsor id="400177" joined="2003-02-13"/>
    <cosponsor id="400178" joined="2003-02-13"/>
    <cosponsor id="400183" joined="2003-02-13"/>
    <cosponsor id="400195" joined="2003-02-13"/>
    <cosponsor id="400216" joined="2003-03-06"/>
    <cosponsor id="400282" joined="2003-02-13"/>
    <cosponsor id="400356" joined="2003-02-13"/>
    <cosponsor id="400357" joined="2003-02-13"/>
    <cosponsor id="400363" joined="2003-02-13"/>
    <cosponsor id="400378" joined="2003-02-13"/>
    <cosponsor id="400389" joined="2003-02-13"/>
    <cosponsor id="400399" joined="2003-02-13"/>
    <cosponsor id="400410" joined="2003-02-13"/>
    <cosponsor id="400415" joined="2003-03-06"/>
    <cosponsor id="400436" joined="2003-02-13"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2003-02-13">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2003-02-26">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Commerce"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Foreign trade and international finance"/>
    <term name="Government operations and politics"/>
    <term name="Imports"/>
    <term name="Labeling"/>
    <term name="Law"/>
    <term name="Pharmacies"/>
    <term name="Pharmacists"/>
    <term name="Prescription pricing"/>
    <term name="Wholesale trade"/>
  </subjects>
  <amendments/>
  <summary>2/13/2003--Introduced.
Prescription Drug Price Reduction Act - Amends the Federal Food, Drug, and Cosmetic Act to repeal the condition on the permission to pharmacists and wholesalers to import prescription drugs from Canada into the United States that the Secretary first demonstrate to Congress the safety of such products and the financial benefit to consumers of permitting their importation. (Thus allows the importation of such drugs to proceed without fulfillment of prerequisites.) Repeals termination of the importation program. Directs the Secretary to promulgate a final rule for carrying out the provisions on covered products within a year of the enactment of this Act, with the effective date for such final rule to be no later than 30 days after the date of promulgation.Classifies an imported covered product as misbranded unless it bears labeling that identifies: (1) the country of origin; (2) the name and address of the importer; and (3) the name and address of the person who exported the product to the United States.</summary>
</bill>
